Overview Dividends

(AVNT) Avient - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US05368V1061

Colorants, Additives, Inks, Polymer Formulations, Specialty Materials

Specialty Chemicals
Market Cap in USD: 2,817m

IPO / Inception: 1999-09-13
Return 12m vs S&P 500: -34.6%

EPS (Earnings per Share)

EPS CAGR: 5.14%
EPS Trend: -10.9%

Last SUE: 0.00
Qual. Beats: 0

Revenue

Rev. CAGR: -10.08%
Rev. Trend: -48.3%

Last SUE: -0.90
Qual. Beats: 0

Dividends

Dividend Yield	3.49%
Yield on Cost 5y	3.06%
Yield CAGR 5y	6.16%
Payout Consistency	68.0%
Payout Ratio	43.1%

Risk via 5d forecast
Volatility	30.7%
Value at Risk 5%th	47.1%
Relative Tail Risk	-6.89%

Reward TTM
Sharpe Ratio	-0.63
Alpha	-47.85
CAGR/Max DD	0.00

Character TTM
Hurst Exponent	0.634
Beta	1.375
Beta Downside	1.378

Drawdowns 3y
Max DD	46.87%
Mean DD	16.32%
Median DD	12.54%

Description: AVNT Avient November 09, 2025

Avient Corp (NYSE:AVNT) is a global material-solutions provider operating in two segments: Color, Additives & Inks, and Specialty Engineered Materials. The company formulates custom color concentrates, liquid systems (e.g., polyester, polyurethane, silicone) and specialty inks for thermoplastics and thermosets, serving end-markets such as medical devices, food packaging, automotive, construction, and consumer apparel. Its Specialty Engineered Materials arm delivers polymer formulations and processing services for designers and manufacturers of thermoplastic components, selling primarily through direct sales teams, distributors, and commissioned agents.

Based on Avient’s 2023 Form 10-K, the firm generated roughly $2.0 billion in revenue with an adjusted EBITDA margin of about 10%, reflecting modest profitability in a sector where raw-material (petrochemical) price volatility is a key cost driver. Recent quarterly reports show a 4% year-over-year increase in sales to the packaging and medical segments-areas benefitting from heightened demand for recyclable and sterile materials. A notable sector trend is the shift toward sustainable polymers, which is expected to boost demand for Avient’s high-performance, low-VOC formulations.

For a deeper dive into Avient’s valuation metrics and peer comparison, you might explore the analysis on ValueRay.

Piotroski VR‑10 (Strict, 0-10) 4.0

Net Income (113.3m TTM) > 0 and > 6% of Revenue (6% = 194.8m TTM)

FCFTA 0.02 (>2.0%) and ΔFCFTA -0.21pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 22.25% (prev 17.52%; Δ 4.73pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.04 (>3.0%) and CFO 256.4m > Net Income 113.3m (YES >=105%, WARN >=100%)

Net Debt (1.53b) to EBITDA (400.6m) ratio: 3.81 <= 3.0 (WARN <= 3.5)

Current Ratio 2.03 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (91.8m) change vs 12m ago -0.22% (target <= -2.0% for YES)

Gross Margin 32.21% (prev 31.31%; Δ 0.89pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 53.64% (prev 53.13%; Δ 0.51pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 2.02 (EBITDA TTM 400.6m / Interest Expense TTM 119.4m) >= 6 (WARN >= 3)

Altman Z'' 2.56

(A) 0.12 = (Total Current Assets 1.42b - Total Current Liabilities 701.6m) / Total Assets 6.06b

(B) 0.31 = Retained Earnings (Balance) 1.87b / Total Assets 6.06b

(D) 0.48 = Book Value of Equity 1.76b / Total Liabilities 3.67b

Total Rating: 2.56 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 44.31

1. Piotroski 4.0pt

2. FCF Yield 3.48%

3. FCF Margin 4.65%

4. Debt/Equity 0.83

5. Debt/Ebitda 3.81

6. ROIC - WACC (= -2.82)%

7. RoE 4.85%

8. Rev. Trend -48.32%

9. EPS Trend -10.88%

What is the price of AVNT shares?

As of December 21, 2025, the stock is trading at USD 31.09 with a total of 652,697 shares traded.
Over the past week, the price has changed by +0.42%, over one month by +11.38%, over three months by -10.75% and over the past year by -23.10%.

Is AVNT a buy, sell or hold?

Avient has received a consensus analysts rating of 4.33. Therefore, it is recommended to buy AVNT.

Strong Buy: 4
Buy: 0
Hold: 2
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the AVNT price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	41	31.9%
Analysts Target Price	41	31.9%
ValueRay Target Price	31.1	0.2%

AVNT Fundamental Data Overview December 19, 2025

Market Cap USD = 2.82b (2.82b USD * 1.0 USD.USD)
P/E Trailing = 25.0163
P/E Forward = 10.2041
P/S = 0.8679
P/B = 1.1771
P/EG = 1.0201
Beta = 1.469
Revenue TTM = 3.25b USD
EBIT TTM = 241.4m USD
EBITDA TTM = 400.6m USD
Long Term Debt = 1.97b USD (from longTermDebt, last quarter)
Short Term Debt = 500.0k USD (from shortTermDebt, last quarter)
Debt = 1.97b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.53b USD (from netDebt column, last quarter)
Enterprise Value = 4.34b USD (2.82b + Debt 1.97b - CCE 445.6m)
Interest Coverage Ratio = 2.02 (Ebit TTM 241.4m / Interest Expense TTM 119.4m)
FCF Yield = 3.48% (FCF TTM 151.1m / Enterprise Value 4.34b)
FCF Margin = 4.65% (FCF TTM 151.1m / Revenue TTM 3.25b)
Net Margin = 3.49% (Net Income TTM 113.3m / Revenue TTM 3.25b)
Gross Margin = 32.21% ((Revenue TTM 3.25b - Cost of Revenue TTM 2.20b) / Revenue TTM)
Gross Margin QoQ = 30.37% (prev 32.07%)
Tobins Q-Ratio = 0.72 (Enterprise Value 4.34b / Total Assets 6.06b)
Interest Expense / Debt = 1.68% (Interest Expense 33.2m / Debt 1.97b)
Taxrate = 23.54% (10.1m / 42.9m)
NOPAT = 184.6m (EBIT 241.4m * (1 - 23.54%))
Current Ratio = 2.03 (Total Current Assets 1.42b / Total Current Liabilities 701.6m)
Debt / Equity = 0.83 (Debt 1.97b / totalStockholderEquity, last quarter 2.37b)
Debt / EBITDA = 3.81 (Net Debt 1.53b / EBITDA 400.6m)
Debt / FCF = 10.10 (Net Debt 1.53b / FCF TTM 151.1m)
Total Stockholder Equity = 2.34b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.87% (Net Income 113.3m / Total Assets 6.06b)
RoE = 4.85% (Net Income TTM 113.3m / Total Stockholder Equity 2.34b)
RoCE = 5.60% (EBIT 241.4m / Capital Employed (Equity 2.34b + L.T.Debt 1.97b))
RoIC = 4.23% (NOPAT 184.6m / Invested Capital 4.37b)
WACC = 7.05% (E(2.82b)/V(4.79b) * Re(11.08%) + D(1.97b)/V(4.79b) * Rd(1.68%) * (1-Tc(0.24)))
Discount Rate = 11.08% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.05%
[DCF Debug] Terminal Value 68.13% ; FCFE base≈156.1m ; Y1≈157.2m ; Y5≈169.3m
Fair Price DCF = 20.45 (DCF Value 1.87b / Shares Outstanding 91.6m; 5y FCF grow 0.29% → 3.0% )
EPS Correlation: -10.88 | EPS CAGR: 5.14% | SUE: 0.0 | # QB: 0
Revenue Correlation: -48.32 | Revenue CAGR: -10.08% | SUE: -0.90 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.82 | Chg30d=+0.021 | Revisions Net=-2 | Analysts=5
EPS next Year (2026-12-31): EPS=3.06 | Chg30d=-0.026 | Revisions Net=-4 | Growth EPS=+8.7% | Growth Revenue=+2.2%

Additional Sources for AVNT Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle